Immune reconstitution inflammatory syndrome (IRIS) in a patient with neuro pulmonary nocardiosis following hematopoietic cells transplantation (HCT). Issue 2 (February 2022)

• Record Type: Journal Article
• Authors: Gur, Ivan; Petersiel, Neta; Karban, Amir; Zuckerman, Tzila; Oren, Ilana; Stern, Anat
• Is Part Of: Journal of infection and chemotherapy. Volume 28:Issue 2(2022)
• Page Start: 311
• Page End: 314
• Publication Date: 2022-02
• Subjects: Hematopoietic cells transplantation (HCT) -- Invasive nocardiosis -- Immune reconstitution inflammatory syndrome (IRIS); ART antiretroviral therapy -- CNS central nervous system -- CSA cyclosporine -- GvHD graft versus host disease -- HCT hematopoietic cell transplant -- HIV human immunodeficiency virus -- IRIS immune reconstitution inflammatory syndrome -- MMF mycophenolate mofetil -- TMP-SMX trimethoprim-sulfamethoxazole; Chemotherapy -- Periodicals; Infection -- Periodicals; Communicable diseases -- Chemotherapy -- Periodicals; 615.5805
• DOI: 10.1016/j.jiac.2021.10.031
• Languages: English
• ISSNs: 1341-321X

Abstract

Abstract: Immune reconstitution inflammatory syndrome (IRIS) is increasingly reported in various HIV negative patients with immunosuppression, but the relationship with hematopoietic cell transplantation (HCT) is not well defined. We report a case of IRIS in a patient infected with pulmonary and CNS Nocardiosis following HCT due to primary myelofibrosis.